TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

3.90$ -8.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow FHTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – -7,275.8% -3,809.7% 1,006.9% -345.8% -444.2% -278.6%
– – 308.6% 244.7% 41.1% 10.1% 13.8% 10.8%
– – 688.6% 635.6% 74.6% 47.4% 52.6% 33.6%
– – 1,740.5% 753.2% 74.6% – – –
– – 6,675.1% 2,535.3% 1,464.3% -122.6% -142.8% -104.0%
– – 3,763.5% 251.2% 6.3% 3.6% 4.0% 0.2%
– – -25,328.8% 2,742.5% -1,270.7% 422.9% -132.3% 362.5%
– – 28,684.2% 3,307.3% 9.2% – – –
– – 993.0% -1,607.7% 0.0% – – –
– – 50,575.1% 1,699.6% 9.2% 5.2% 466.5% 3.3%
– – 17,970.5% 632.4% -254.4% 82.3% -110.1% 87.2%
– – -11,039.3% -4,060.9% 1,000.6% -349.4% -448.2% -278.7%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?